Top Markets
Coin of the day
Lisata Therapeutics, Inc. Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc.

LSTA
주식 순위 #32451
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on... Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues. The company's product portfolio features several notable candidates: HONEDRA, which has received SAKIGAKE designation and is presently in Phase II clinical trials for critical limb ischemia; XOWNA, currently undergoing Phase IIb testing for coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy aimed at individuals with chronic kidney disease who are not yet on dialysis. Founded in 1980 and based in Basking Ridge, New Jersey, the company was initially known as NeoStem, Inc., then rebranded as Caladrius Biosciences, Inc. in June 2015, before assuming its present identity as Lisata Therapeutics, Inc. on September 15, 2022.
주가
$1.11
시가총액
$10.06M
변동 (1일)
1.38%
변동 (1년)
-56.32%
국가
US
거래 Lisata Therapeutics, Inc. (LSTA)

카테고리

Lisata Therapeutics, Inc. (LSTA)의 주가 이력
최고 종가: $1.12 (2026-08-01 기준)

최저 종가: $188.93K (1999-03-01 기준)
Lisata Therapeutics, Inc.의 주가 이력 (1999 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 52.31%
2025 -28.03%
2024 3.05%
2023 -6.25%
2022 -78.23%
2021 -42.33%
2020 -36.52%
2019 -44.38%
2018 26.19%
2017 2.72%
2016 -70.04%
2015 -68.59%
2014 -44.74%
2013 2.99%
2012 11.54%
2011 -61.50%
2010 -9.12%
2009 147.46%
2008 -61.79%
2007 -75.15%
2006 19.82%
2005 -7.65%
2004 -69.11%
2003 253.51%
2002 -86.70%
2001 -26.92%
2000 -63.97%
1999 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$515.58 32.24%
US
$992.01 50.00%
NL
$736.64 6.99%
CH
$1.07K -6.01%
KR
$255.50 12.02%
BE